Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuyuki Miyake is active.

Publication


Featured researches published by Nobuyuki Miyake.


Journal of Gastroenterology and Hepatology | 2010

Enteral nutrition decreases hospitalization rate in patients with Crohn's disease

Osamu Watanabe; Takafumi Ando; Kazuhiro Ishiguro; Hironao Takahashi; Daisuke Ishikawa; Nobuyuki Miyake; Tsuyoshi Kato; Satoshi Hibi; Shunya Mimura; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto

Background and Aims:  Crohns disease (CD) is a chronic inflammatory bowel disease with relapse and remission. CD patients are admitted to hospital when bowel inflammation flares up severely, which lowers their quality of life. Enteral nutrition (EN) with an elemental diet plays an important role in the treatment for CD patients in Japan, because of its few adverse effects, and it is thought to be effective in maintaining remission. We investigated the effectiveness of EN with an elemental diet with regard to the avoidance of hospitalization.


Digestion | 2009

Potential Role for Matrix Metallo- proteinase-3 in Gastric Ulcer Healing

Makoto Tomita; Takafumi Ando; Masaaki Minami; Osamu Watanabe; Kazuhiro Ishiguro; Motofusa Hasegawa; Nobuyuki Miyake; Shinya Kondo; Tsuyoshi Kato; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto

Background/Aims: Matrix metalloproteinases (MMPs) are endopeptidases which perform important functions in extracellular matrix remodeling, cell proliferation, and inflammatory processes. Here, we compared MMP-3 levels with those of tissue inhibitor of metalloproteinases (TIMP)-1 and several inflammatory cytokines in gastric ulcer (GU) patients. Methods: This study enrolled 50 patients with GU and 6 with functional dyspepsia (FD). Samples of gastric mucosa from the antrum and the ulcer site were harvested from GU patients and of antral mucosa alone from FD patients during upper gastrointestinal endoscopy. Mucosal biopsy tissues were cultured for 24 h, and the culture supernatant was measured for levels of MMP-3, TIMP-1, IL-1β, IL-6, and IL-8. Results: All GU patients were positive for Helicobacter pylori, while all FD patients were negative. Antral levels of TIMP-1, IL-1β, IL-6, and IL-8 were significantly higher in GU than FD patients. Further, MMP-3 levels were significantly higher in GU patients at the ulcer site than in the antrum, and had a significantly positive correlation with TIMP-1, IL-1β, IL-6, and IL-8. Conclusion: MMP-3 levels were significantly higher at the ulcer site than in the antrum, suggesting that MMP-3 may perform an important function in gastric ulcer healing.


BMC Gastroenterology | 2011

Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis

Daisuke Ishikawa; Takafumi Ando; Osamu Watanabe; Kazuhiro Ishiguro; Osamu Maeda; Nobuyuki Miyake; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yoshiki Hirooka; Emad M. El-Omar; Hidemi Goto

BackgroundReal-time tissue sonoelastography (EG) is a new non-invasive technique that visualizes differences in tissue strain. We evaluated the usefulness of EG in patients with ulcerative colitis (UC) by investigating the association between EG and colonoscopic findings and disease activity.MethodsThirty-seven UC patients undergoing EG and colonoscopy were invited to enroll. EG findings were classified as normal, homogeneous, random, or hard, and colonoscopic findings as normal, mucosal edema and erosion, punched-out ulcer, and extensive mucosal abrasion. Clinical findings were evaluated using clinical activity index (CAI) scores for each patient at colonoscopy.ResultsOn EG, 10 cases were classified as normal, 11 as homogeneous, 6 as random, and 10 as hard. EG findings showed a significant correlation those of colonoscopy (p < 0.001). Seven of 10 (70%) normal-type patients were in the remission phase, while all 6 random-type patients were in the active phase. Among active-phase patients, 4 of 7 (57%) homogeneous-type patients responded to steroid or leukocytapheresis therapy, while 3 of 6 (50%) random-type patients required treatment with cyclosporine. Three of 10 (30%) hard-type patients required colectomy.ConclusionsIn this small series, EG findings reflected colonoscopic findings and correlated with disease activity among patients with UC.


Journal of Gastroenterology and Hepatology | 2010

Restriction-modification systems may be associated with Helicobacter pylori virulence

Takafumi Ando; Kazuhiro Ishiguro; Osamu Watanabe; Nobuyuki Miyake; Tsuyoshi Kato; Satoshi Hibi; Shunya Mimura; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto

Restriction–modification (R‐M) systems are exclusive to unicellular organisms and ubiquitous in the bacterial world. Bacteria use R‐M systems as a defense against invasion by foreign DNA. Analysis of the genome sequences of Helicobacter pylori strains 26 695 and J99 identified an extraordinary number of genes with homology to R‐M genes in other bacterial species. All H. pylori strains possess their own unique complement of active R‐M systems. All of the methylases that have been studied so far were present in all major human population groupings, suggesting that their horizontal acquisition pre‐dated the separation of these populations. The two most strongly conserved methylase genes of H. pylori, hpy IM and hpy IIIM, are both preceded by alternative genes that compete for presence at their loci, and furthermore these genes may be associated with H. pylori pathogenicity. Further study should investigate the roles of H. pylori R‐M systems.


Digestive and Liver Disease | 2009

Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids

Osamu Watanabe; Takafumi Ando; Emad M. El-Omar; Masaaki Shimada; Kenji Ina; Kazuhiro Ishiguro; Motofusa Hasegawa; Nobuyuki Miyake; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yoshimitsu Niwa; Hidemi Goto

BACKGROUND AND AIMS Although cyclosporin A has been reported to be effective in the treatment of severe ulcerative colitis, factors predicting its therapeutic efficacy remain unclear. Technical progress in endoscopic ultrasonography has improved visualisation of the structure of the colon wall. Here, to assess the value of endoscopic ultrasonography in predicting the response to cyclosporin A treatment, we evaluated the therapeutic effect of cyclosporin A by determining the pre- and post-cyclosporin A thickness of the mucosal layer in the rectum using endoscopic ultrasonography with an ultrasonic catheter probe. PATIENTS AND METHODS Fifteen ulcerative colitis patients who did not respond to high-doses of corticosteroids were treated with cyclosporin A by continuous intravenous infusion at 4mg/kg/day for 20 days. Before and 20 days after cyclosporin A therapy, clinical disease activity was assessed using clinical activity index scores. Colonoscopy and endoscopic ultrasonography were undertaken before and 20 days after cyclosporin A therapy. RESULTS Following treatment with cyclosporin A, nine patients showed a decrease in clinical activity index score by six points or more and were defined as responders, while the other six were defined as non-responders. Endoscopic ultrasonography measurement using an ultrasonic catheter probe showed that thickness of the rectal mucosal layer before cyclosporin A was significantly greater in responders than in non-responders (p<0.05). Further, thickness after cyclosporin A was statistically decreased (p<0.01) in the responders but not in the non-responders. CONCLUSIONS The ultrasonic catheter probe may represent a useful means of predicting and evaluating the efficacy of cyclosporin A treatment in severely ill ulcerative colitis patients.


Hepato-gastroenterology | 2010

Clinicopathological Study of Colorectal Cancer Occurring in Patients with Ulcerative Colitis: Results from a Single Hospital in Japan

Takayoshi Fujita; Takafumi Ando; Osamu Watanabe; Motofusa Hasegawa; Nobuyuki Miyake; Shinya Kondo; Tsuyoshi Kato; Kazuhiro Ishiguro; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto


World Journal of Gastroenterology | 2015

Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis

Nobuyuki Miyake; Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Osamu Watanabe; Yutaka Hirayama; Keiko Maeda; Kazuhiro Morise; Masanobu Matsushita; Kazuhiro Furukawa; Kohei Funasaka; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Hidemi Goto


Gastrointestinal Endoscopy | 2010

W1624: Symptoms in Patients With Crohn's Disease Are Related to the Presence of Strictures Rather Than to That of Active Ulcers in the Small Bowel by the Examination of Double-Balloon Enteroscopy

Osamu Watanabe; Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Nobuyuki Miyake; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Hidemi Goto


Gastrointestinal Endoscopy | 2009

W1625: Recurrence of Ulcers After Small Bowel Resection in Patients With Crohn's Disease: Efficacy of Infliximab As Assessed by Double-Balloon Endoscopy

Osamu Watanabe; Takafumi Ando; Kazuhiro Ishiguro; Nobuyuki Miyake; Motofusa Hasegawa; Shinya Kondo; Tsuyoshi Kato; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto


Gastrointestinal Endoscopy | 2010

W1507: Clinicopathological Characteristics of Colorectal Cancer in Patients With Ulcerative Colitis

Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Osamu Watanabe; Nobuyuki Miyake; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Hidemi Goto

Collaboration


Dive into the Nobuyuki Miyake's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge